Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph(CHL)

血液ガス(Pco2、Po2)及び血液pH電極測定装置 この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。

米国回収

176

直近 2026.05.06

510(k)

188

PMA

0

不具合報告

2,392

分類情報

Product Code CHL
デバイス名 Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph

血液ガス(Pco2、Po2)及び血液pH電極測定装置 この日本語名は AI が生成した参考訳です。正式名称は英語の原名です。

デバイスクラス クラス II
21 CFR 規制番号 862.1120
審査区分 510(k)(市販前届出)
医療専門分野 臨床化学
定義
フラグ
該当なし
AI分析

本品は米国FDAの規制上クラスIIに分類される医療機器であり、市販前届出(510(k))の対象となっています。クラスIIは中程度のリスクを有する機器区分であり、市販前届出により安全性及び有効性に関する適合性が確認されることで市販が認められます。

米国市場での動向

本製品コードでは、510(k)が累計約190件届出されており、参入企業は59社、直近5年間では約10件の届出が確認されています。不具合報告は累計約2,400件で、その大半が不具合(Malfunction)による報告であり、死亡報告は46件、傷害報告は約70件となっています。主な問題としては、Incorrect, Inadequate or Imprecise Result or Readings(不正確・不十分・不精密な結果または読み取り値)、Low Test Results(低い検査結果)、High Test Results(高い検査結果)が挙げられています。回収は累計約180件で、クラスIの報告は確認されていませんが、クラスIIが約130件、クラスIIIが1件含まれ、直近5年間では約60件、最新の回収は2026年5月に開始されています。

この分析は公開データ(openFDA・JMDN 対応情報)をもとに AI が生成した参考情報です。市場データは2026年8月時点の集計に基づきます。

関連 product code

同じ 21 CFR 862.1120 に分類される product code(1 件)

No.product code機器名クラス専門分野510(k)PMA不具合回収
1SFO

Electrode Measurement, Drain Effluent Ph

排液流出液pH測定電極

II臨床化学1

機器名の日本語訳は AI により自動生成したものです。正確には英語原文をご確認ください。

類似の国内医療機器(自動推定)

FDA デバイス分類と JMDN 英語名の名称・定義文の類似度から機械的に推定した候補です。日米の当局が定めた公的な対応関係ではなく、参考情報としてご覧ください。

No.類別一般的名称品目数企業数年間総出荷額成長率平均価格国産比率
1内臓機能検査用器具血液ガス酸素分析装置クラスⅠ
2内臓機能検査用器具汎用血液ガス分析装置クラスⅠ43861.51 億円/年-2.1% 2.73 万円/個3.0%
3内臓機能検査用器具経皮血液ガスセンサクラスⅡ22
4内臓機能検査用器具経皮血中ガス分析装置クラスⅡ53

FDA のデバイスクラスは 3 段階(クラス I〜III)、日本の医療機器は 4 段階(クラス I〜IV)で分類されており、 1 対 1 では対応しません。 リスク区分の考え方が異なるため、参考情報としてご利用ください。

米国での回収・承認・不具合報告

無料会員 1,000名 突破

回収・承認・不具合報告の明細の閲覧は会員限定です

無料で会員登録する
回収番号クラス回収開始日企業理由ステータス
Z-2005-2026 CHLクラス II2026.04.02Siemens Healthcare Diagnostics Inc

Use of the affected product can result in discrepant low pH and measured Total Carbon Dioxide (mTCO2) results and corresponding calculated values in arterial, venous, and capillary patient samples. An erroneously low pH or mTCO2 reading can lead to inappropriate treatment of nonexistent acidosis (respiratory of metabolic) or missed diagnosis of alkalosis (a true high pH: respiratory or metabolic alkalosis), potentially causing harm through unnecessary interventions with the former or failure to deliver appropriate treatment with the latter.

対応中
Z-2001-2026 CHLクラス II2026.04.01Abbott Point Of Care Inc.

Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

対応中
Z-2000-2026 CHLクラス II2026.04.01Abbott Point Of Care Inc.

Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

対応中
Z-1999-2026 CHLクラス II2026.04.01Abbott Point Of Care Inc.

Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

対応中
Z-1543-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1542-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1541-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1540-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1539-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1538-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1537-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1536-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1535-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1534-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1533-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1532-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1531-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1530-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1529-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中
Z-1528-2026 CHLクラス II2026.01.20Instrumentation Laboratory

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.

対応中

510(k)(市販前届出)

全 188 件
No.番号機器名申請者決定日種別概要
1K252207 ABL90 FLEX PLUS System, safeCLINITUBESRadiometer Medicals Aps2026.04.10通常(Traditional) PDF
2K244014 i-STAT CG4+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.2025.05.02通常(Traditional) PDF
3K240998 ABL90 FLEX PLUS SystemRadiometer Medicals Aps2024.12.13通常(Traditional) PDF
4K230285 i-STAT CG8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.2023.10.27通常(Traditional) PDF
5K221900 Stat Profile Prime Plus Analyzer SystemNova Biomedical Corporation2023.09.29通常(Traditional) PDF
6K223857 i-STAT G3+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.2023.09.15通常(Traditional) PDF
7K223608 GEM Premier 7000 with IQM3Instrumentation Laboratory Company2023.08.10通常(Traditional) PDF
8K211559 EasyStat 300Medica Corporation2023.01.27通常(Traditional) PDF
9K203790 GEM Premier 5000Instrumentation Laboratory CO2021.08.20特別(Special) PDF
10K200986 OPTI® B-Lac CassetteOpti Medical Systems, Inc.2021.08.02通常(Traditional) PDF
11K200107 epoc Blood Analysis SystemEpocal, Inc.2020.06.05特別(Special) PDF
12K200492 i-STAT CG4+ Cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.2020.04.09通常(Traditional) PDF
13K192240 RAPIDPoint 500e Blood Gas SystemSiemens Healthcare Diagnostics, Inc.2020.03.27特別(Special) PDF
14K193246 Stat Profile Prime Plus Analyzer SystemNova Biomedical Corporation2020.01.24通常(Traditional) PDF
15K173797 Stat Profile Prime Plus Analyzer SystemNova Biomedical Corporation2018.07.17通常(Traditional) PDF
16K173403 GEM Premier 5000Instrumentation Laboratory CO2017.12.29通常(Traditional) PDF
17K160412 GEM Premier 5000 (Measured Parameters: pH, pCO2 and pO2)Instrumentation Laboratory CO2016.12.14通常(Traditional) PDF
18K160153 ABL90 FLEX PLUSRadiometer Medical Aps2016.11.04特別(Special) PDF
19K151978 EDAN i15 Blood Gas and Chemistry Analysis System, EDAN i15 Calibrant Fluid Pack, EDAN i15 Blood Gas and Electrolyte Control, EDAN i15 Hematocrit ControlEdan Instruments, Inc.2016.07.15通常(Traditional) PDF
20K151982 Stat Profile Prime ABG Analyzer SystemNova Biomedical Corporation2015.09.10通常(Traditional) PDF

出典の openFDA は各 510(k) の主要(primary)product code のみを収録しているため、副次コードを含む FDA 公式データベースの検索結果とは件数が異なる場合があります。 FDA 510(k) データベースで確認

PMA(市販前承認)

この product code の PMA 情報はありません。

不具合報告(MAUDE)トレンド

米国不具合報告検索で詳しく見る

出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。

報告の存在は、機器と事象の因果関係を意味しません。報告件数を機器間の不具合発生率の比較に用いることはできません。

各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。

不具合報告データを読み込み中...

出典: openFDA(U.S. FDA) のデータをそのまま掲載しています。内容の正確性・最新性は保証されません。FDA が本サイトの内容を承認・保証するものではありません。

取得日: 2026.09.07

各データセット(510(k)・PMA・MAUDE・回収・Warning Letter)の解説は 米国FDA情報の概要 を参照してください。